Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

SDHD Inhibitors

SDHD inhibitors encompass a diverse class of chemicals that impede the function of the succinate dehydrogenase complex subunit D, a critical component of the mitochondrial electron transport chain and the tricarboxylic acid (TCA) cycle. These inhibitors act upon SDHD by different modes of action, such as competitive inhibition, where the inhibitor molecule competes with succinate for the active site of the enzyme. Malonate and oxaloacetate are quintessential examples of such competitive inhibitors. Others, like 3-nitropropionic acid, covalently bind to and modify the enzyme's active site, thereby inhibiting enzyme activity irreversibly.Several SDHD inhibitors interfere with the ubiquinone binding site, which is essential for electron transfer within the mitochondrial electron transport chain. Atpenin A5, TTFA, and Carboxin are examples of compounds that bind to this site, thereby disrupting the electron flow from SDHD to ubiquinone. This inhibition can affect the TCA cycle, as SDHD is also involved in the conversion of succinate to fumarate in this cycle. Additionally, the modulation of SDHD activity impacts cellular respiration and energy production, given that SDHD plays a pivotal role in coupling the TCA cycle with oxidative phosphorylation. Some inhibitors like alpha-ketoglutarate act as feedback inhibitors, which naturally regulate the enzyme's activity within the cell. The inhibition of SDHD by such compounds reflects the intricacies of metabolic control and the tight regulation of enzymatic activity through substrate availability and feedback mechanisms. The chemicals that target SDHD may also include those that structurally mimic its substrates or products, thereby blocking the active site. This category includes dimethyl malonate and phenylpyruvate. Moreover, certain methylenedioxyphenyl compounds, which can have variable structures, are known to modify the active site of SDHD, leading to enzyme inhibition. These inhibitors demonstrate the ability of small molecules to interfere with the normal function of SDHD, impacting various biological pathways and cellular processes where SDHD is involved.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Atpenin A5

119509-24-9sc-202475
sc-202475A
sc-202475B
sc-202475C
250 µg
1 mg
10 mg
50 mg
$195.00
$540.00
$2905.00
$12885.00
17
(1)

Atpenin A5 functions as a selective inhibitor of succinate dehydrogenase (SDH), characterized by its ability to disrupt the enzyme's catalytic cycle through unique binding interactions. This compound alters the conformational dynamics of SDH, leading to a significant decrease in electron transfer efficiency. Its distinct molecular architecture promotes specific interactions with the enzyme's active site, effectively modulating the flow of metabolites and impacting overall cellular energy metabolism.

3-Nitropropionic acid

504-88-1sc-214148
sc-214148A
1 g
10 g
$82.00
$459.00
(1)

Irreversibly inhibits SDH by covalently modifying the active site, blocking the catalytic cycle.

2-Thenoyltrifluoroacetone

326-91-0sc-251801
5 g
$37.00
1
(1)

Interferes with electron transfer by binding to the ubiquinone binding site of SDH.

Carboxine

5234-68-4sc-234286
250 mg
$21.00
1
(1)

Inhibits fungal SDH by binding to the ubiquinone site, reducing electron transport.

Dimethyl malonate

108-59-8sc-239778
sc-239778A
250 ml
1 L
$50.00
$104.00
1
(0)

Can inhibit SDH by competing with succinate as it resembles the natural substrate.

Oxaloacetic Acid

328-42-7sc-279934
sc-279934A
sc-279934B
25 g
100 g
1 kg
$306.00
$963.00
$7980.00
1
(0)

Inhibits SDH indirectly by competing with succinate as a substrate analog.